Jon Cohen
Staff Writer at Science Magazine
Science magazine staff writer on infectious diseases, outbreaks, immunology, vaccines, global health, genomics, CRISPR, surfing. Views mine. @[email protected]
Articles
-
5 days ago |
science.org | Jon Cohen
When The Wall Street Journal reported on 1 May that President Donald Trump’s administration was shifting $500 million meant for improving COVID-19 vaccines to develop more ambitious “universal” vaccines for multiple strains of flu and coronaviruses, many infectious disease scientists and vaccine developers were puzzled.
-
1 week ago |
science.org | Meredith Wadman |Jon Cohen |Jocelyn Kaiser
In a blow to many foreign medical researchers who rely on U.S. funding, the National Institutes of Health (NIH) announced yesterday that by the end of September, it will halt what are known as “foreign subawards,” in which U.S. researchers share their grant money with overseas collaborators.
-
2 weeks ago |
science.org | Jon Cohen
Jeffery Taubenberger, who gained fame for unearthing samples of the 1918 flu virus, and ultimately sequencing its entire genome, has been named acting director of the National Institute of Allergy and Infectious Diseases (NIAID), Science has learned. Taubenberger, who has been an intramural researcher at NIAID for nearly 19 years, replaces HIV/AIDS researcher Jeanne Marrazzo, whom President Donald Trump’s administration removed from the job on 31 March.
-
3 weeks ago |
science.org | Jon Cohen
The U.S. National Institutes of Health (NIH) has now restricted South Africa from participating in clinical trial networks that study new medicines to prevent and treat HIV—compounding the damage to the country’s HIV efforts from President Donald Trump’s administration’s earlier foreign research funding cuts and its dismantling of the U.S. Agency for International Development.
-
1 month ago |
science.org | Jon Cohen
$Please enter a valid amountEmail:Please enter a valid emailCountry:Ialso wish to receive emails from AAAS/Science and Science advertisers,including information on products, services and special offers which mayinclude but are not limited to news, careers information & upcomingevents. Support nonprofit science journalismSophisticated, trustworthy reporting about science has never been more important.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 41K
- Tweets
- 3K
- DMs Open
- Yes
Here's the kind of problem you want to have: Uganda's Ebola cases are dwindling thanks to aggressive containment efforts, but success complicates plans for a rapidly organized trial to do first read-world test of vaccines against Sudan ebolavirus. https://t.co/6dKwPvkLCs https://t.co/MEkoszRzFK
Ask @SetteLab. I'm not aware of any compelling evidence that SARS-CoV-2 depletion of T or B cells has any significant, longterm impact on the immune system's ability to replace them. SRCV2 doesn't target immune cells, and it's not HIV.
@thilogross @manlius84 @DirkBrockmann @sciencecohen and/or @angie_rasmussen might know if there's any evidence for this.
As story explains, this isn't all-or-nothing phenomenon. “I think of interference as a small push,” says Aubree Gordon....“It depends on population immunity and when that virus last circulated and flu and COVID vaccination rates.” But interference is a real phenomenon.
@Ivriniel @OrangeInvasion @Aaron_Derfel @EricTopol @ScienceMagazine @sciencecohen @CovidEcoles Yep. México City just hosted a 100k pple music fest during 3 consecutive days. And the reports of respiratory symptons are flooding twitter. Here is a coinfection (Influenzavirus + COVID) that emerged from there. https://t.co/CaNM0Ss18q